Autopsy report · NCT00515580

Minimally Invasive Tongue Suture For Obstructive Sleep Apnea

“Results from first few subjects was not significantly improved over standard, traditional procedures.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years before it stopped.
• 5 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

West Side ENT

Sponsor type

University, hospital or other

Conditions

Obstructive Sleep Apnea; Upper Airway Resistance Syndrome

Interventions

Tongue Sutures for Obstructive Sleep Apnea

Participants

5

Sites

2

Countries

United States

Trials that died the same way

• OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)
  “The primary endpoint was not achieved in the study.” (63% match in meaning)
• BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
  “Results from pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.” (62% match in meaning)
• A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
  “The response rate observed in the phase 1 portion of the study did not merit further evaluation in phase 2 portion of the study.” (62% match in meaning)
• Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
  “The study had poor efficacy.” (61% match in meaning)
• A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
  “The study did not meet the primary endpoint.” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.